Abstract

Covid-19 far reaching, which was caused by the novel SARS CoV-2, has had an influence so significant and wide that it is touching around the world prosperity. In spite of the fact that it is considered a respiratory infection truly, discoveries from most current considers appear signs proposing that the living being attacks and dispenses wounds on other organ frameworks such as a neural framework.. Several mechanisms have been proposed to explain how such pathological neural changes could be related or linked to infections by SARS CoV-2 virus. These include possible neuroinvasion by the virus presumed to be through olfactory pathway since the resulting neurological symptoms are anosmia and ageusia. It induces hyperinflammation, the so-called cytokine storm, as part neuroinflammatory changes with sequel development concerning neurologically relevant complications. Neurological manifestations are variable and include: mild to moderate cognitive impairment, and headache; in more severe cases, encephalopathies, stroke, and Guillain-Barré syndrome. The so-called long COVID as as often as possible as conceivable sets neurological signs with fundamental potential disappointments from these in quality of life.

• 1.   Zhou, P., Yang, X. L., Wang, X. G., et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579, 270–273.
• 2.   Wu, F., Zhao, S., & Yu, B., et al. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579, 265–269.
• 3.   Wu, J. T., Leung, K., & Leung, G. M. (2020). Nowcasting and forecasting the potential domestic and international spread of the 2019- nCoV outbreak originating in Wuhan, China: A modelling study. Lancet, 395, 689–697.
• 4.   Deng, S. Q., & Peng, H. J. (2020). Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. Journal of Clinical Medicine, 9, 575.
• 5.   Zhu, N., et al. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine, 382, 727–733.
• 6.   Gralinski, L. E., & Menachery, V. D. (2020). Return of the coronavirus: 2019-nCoV. Viruses, 12, 135.
• 7.   Wu, Z., & McGoogan, J. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA, 323, 1239–1242.
• 8.   Mishra dev brat et al. Vol. 9(6), 2020 pp. 7522-7527 www.mutagens.co.in/jgb/vol.09/06/090606. pdf
• 9.   HASÖKSÜZ, M., KILIÇ, S., & SARAÇ, F. (2020). Coronaviruses and SARS-CoV-2. Turkish Journal of Medical Sciences, 50(9), Article 10.
• 10.   Weiss, S. R., & Leibowitz, J. L. (2011). Coronavirus pathogenesis. Advances in Virus Research, 81, 85-164.
• 11.   Masters, P. S., & Perlman, S. (2013). Coronaviridae. In Knipe, D. M., & Howley, P. M. (Eds.), Fields virology (6th ed., pp. 825-858) Lippincott Williams & Wilkins.
• 12.   Su, S., Wong, G., & Shi, W., et al. (2016). Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends in Microbiology, 24, 490–502.
• 13.   Cui, J., Li, F., & Shi, Z. L. (2019). Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, 17, 181-192.
• 14.   Zhong, N. S., Zheng, B. J., Li, Y. M., et al. (2003). Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February 2003. Lancet, 362, 1353-1358.
• 15.   Ksiazek, T. G., Erdman, D., Goldsmith, C. S., et al. (2003). A novel coronavirus associated with severe acute respiratory syndrome. New England Journal of Medicine, 348, 1953–1966.
• 16.   Drosten, C., Günther, S., Preiser, W., et al. (2003). Identification of a novel coronavirus in patients with severe acute respiratory syndrome. New England Journal of Medicine, 348, 1967–1976.
• 17.   Tobin, M. J., Laghi, F., & Jubran, A. (2020). Why COVID-19 silent hypoxemia is baffling to physicians. American Journal of Respiratory and Critical Care Medicine, 202(3), 356–360.
• 18.   Varatharaj, A., Thomas, N., & Ellul, M., et al. (2020). UK-wide surveillance of neurological and neuropsychiatric complications of COVID-19: The first 153 patients. SSRN, 3601761.
• 19.   Lodigiani, C., Iapichino, G., & Carenzo, L., et al. (2020). Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thrombosis Research, 19, 9–14.
• 20.   Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., et al. (2020). Neurological associations of COVID-19. Lancet Neurology, 19(9), 767–783.
• 21.   Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., et al. (2020). UK-wide surveillance of neurological and neuropsychiatric complications of COVID-19: The first 153 patients. SSRN.
• 22.   Bernard-Valnet, R., Pizzarotti, B., & Anichini, A. et al. (2020). Two patients with acute meningoencephalitis concomitant to SARS-CoV-2 infection. European Journal of Neurology.
• 23.   Sohal, S., & Mossammat, M. (2020). COVID-19 presenting with seizures. IDCases, 20, e00782.
• 24.   Slooter, A. J., Otte, W. M., & Devlin, J. W., et al. (2020). Updated nomenclature of delirium and acute encephalopathy: Statement of ten societies. Intensive Care Medicine, 46, 1020– 1022.
• 25.   Zanin, L., Saraceno, G., Panciani, P. P., et al. (2020). SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochirurgica (Wien).
• 26.   Zhang, T., Rodricks, M. B., & Hirsh, E. (2020). COVID-19-associated acute disseminated encephalomyelitis: A case report.
• 27.   Baig, A. M., Khaleeq, A., Ali, U., & Syeda, H. (2020). Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, HostVirus Interaction, and Proposed Neurotropic Mechanisms. ACS Chemical Neuroscience, 11(7), 995-998.
• 28.   Zubair, A. S., McAlpine, L. S., Gardin, T., Farhadian, S., Kuruvilla, D. E., & Spudich, S. (2020). Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurology, 77(8), 1018-1027.
• 29.   Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., ... & Yang, C. (2020). Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, Behavior, and Immunity, 87, 18-22.
• 30.   Li, Y. C., Bai, W. Z., & Hashikawa, T. (2020). The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients. Journal of Medical Virology, 92(6), 552-555.
• 31.   Lechien, J. R., Chiesa-Estomba, C. M., & De Siati, D. R., et al. (2020). Olfactory and gustatory dysfunctions as a clinical presentation of mildto-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. European Archives of Oto-Rhino-Laryngology.
• 32.   Aghagoli, G., Gallo Marin, B., & Katchur, N. J. et al. (2021). Neurological involvement in COVID-19 and potential mechanisms: A review. Neurocritical Care, 34, 1062–1071.
• 33.   Gutierrez-Ortiz, C., Mendez, A., & RodrigoRey, S. (2020). Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology, 95(9), 408.
• 34.   Karimi, N., Razavi, A. S., & Rouhani, N. (2020). Frequent convulsive seizures in an adult patient with COVID-19: A case report. Iranian Red Crescent Medical Journal, 22(3), e102828.
• 35.   Zhao, H., Shen, D., Zhou, H., Liu, J., & Chen, S. (2020). Guillain-Barre syndrome associated with SARS-CoV-2 infection: Causality or coincidence? Lancet Neurology, 19(5), 383–384.
• 36.   Netland, J., Meyerholz, D. K., Moore, S., Cassell, M., & Perlman, S. (2008). Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. Journal of Virology, 82(15), 7264–7275.
• 37.   Desforges, M., Le Coupanec, A., Brison, E., Meessen-Pinard, M., & Talbot, P. J. (2014). Neuroinvasive and neurotropic human respiratory coronaviruses: Potential neurovirulent agents in humans. Advances in Experimental Medicine and Biology, 807, 75–96.
• 38.   Paniz-Mondolfi, A., Bryce, C., Grimes, Z., Gordon, R. E., Reidy, J., Lednicky, J., Sordillo, E. M., & Fowkes, M. (2020). Central nervous system involvement by severe acute respiratory syndrome coronavirus–2 (SARSCoV-2). Journal of Medical Virology, 92(7), 699–702.
• 39.   Sankowski, R., Mader, S., & Valdes-Ferrer, S. I. (2015). Systemic inflammation and the brain: Novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration. Frontiers in Cellular Neuroscience, 9(28), 28.
• 40.   Goërtz, Y. M. J., et al. (2020). Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res, 6(4), 00542-2020.

Data Sharing Statement

Funding